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740ORRI
¼ baseline life
shortest plaque life among all crack initializations
and the acute rupture risk index (ARRI) was deﬁned
as maximum of the rupture risk index among all
cracks ruptured at the pool, that is:
ARRI ¼ baseline life
shortest plaque life among all acute ruptures
The Young’s modulus of the arterial wall, the
ﬁbrous cap, and the lipid pool was chosen as 0.3, 0.6,
and 0.02 Mpa, respectively. Poisson’s ratio for all
components was set equally as 0.48. The fatigue pa-
rameters c and m were chosen as 1 and 2.6. Figure 1B
shows the ﬁnite element modeling process for 1 case.
The ARRI values in plaques of symptomatic patients
were signiﬁcantly higher than those of asymptomatic
patients (44.2  62.6 vs. 10.6  17.7, p ¼ 0.003).
No difference was found for the ORRI value (p ¼ 0.61).
It is interesting to ﬁnd an obvious difference of the
ORRI rupture path between the symptomatic and
asymptomatic patients. In the symptomatic group,
78% (14 of 18) of the ORRI rupture path was toward the
lipid pool; in contrast, there were only 12% (2 of 16) for
the asymptomatic group. It seems that the cross-
sectional geometry of an asymptomatic patient may
successfully avoid an acute pool-rupture event.
Figure 1C shows RRI results for 1 symptomatic patient
and 1 asymptomatic patient.
The risk index deﬁned here is a composite factor,
which comprises vessel cross-sectional geometry,
material property, blood pressure, heart rate, and so
on. It is also an overall value on the whole rupture
path, so that local high stress may not signiﬁcantly
affect it. This ﬁnding may indicate that fatigue crack
growth under pulsatile pressure is a mechanism for
atheromatous plaque rupture. Thus, the fatigue
model may be a useful tool to predict and assess
plaque vulnerability, if further validated by large-
scale longitudinal studies.Xuan Pei, MSc
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of Tako-Tsubo CardiomyopathyWe greatly enjoyed reading the paper by Citro
et al. (1), entitled “Echocardiographic Correlates of
Acute Heart Failure, Cardiogenic Shock, and In-
Hospital Mortality in Tako-Tsubo Cardiomyopathy,”
which was recently published in iJACC. The investi-
gators (1) sought to determine the clinical and echo-
cardiographic correlates of acute heart failure,
cardiogenic shock, and in-hospital mortality in Tako-
Tsubo cardiomyopathy (TTC) patients. Although we
commend the investigators for their valuable study
and the data that they provided, some comments may
be beneﬁcial.
In the study, the diagnosis of TTCwas on the basis of
Mayo Clinic criteria, and the investigators mentioned
that performing cardiac magnetic resonance (CMR)
was not available in the early evaluation of patients
with acute coronary syndrome or similar conditions.
In patients with myocardial infarction-like clinical
syndromes (e.g., myocarditis, coronary vasospasm,
and TTC), further evaluation should be planned to
detect etiology and manage speciﬁc treatment. When
the etiology remains unclear and needs to be deter-
mined precisely, CMR appears to be a useful imaging
modality for establishing the diagnosis and differen-
tiating it from the etiology of cardiac wall motion ab-
normalities (2). Infarct-like clinical syndromes are
characteristic in late gadolinium enhancement (LGE)
patterns (2,3). No or minimal LGE on CMR imaging
is characteristic in TTC, and mid-myocardial LGE is
characteristic in myocarditis, whereas subendocardial
LGE is characteristic in myocardial infarction (2,3).
Establishing the exact etiology of cardiac wall motion
abnormalities will help in management, thereby
avoiding harmful medications and interventions.
The investigators also mentioned that in patients
with left ventricular (LV) outﬂow tract obstruction
(LVOTO) and markedly impaired LV systolic function,
beta-blockade and intra-aortic balloon counter-
pulsation should be the preferred treatment options,
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741compared with inotropic agents, to prevent the
development of signiﬁcant intraventricular gradients
and subsequent hemodynamic deterioration. A word
of caution should be added—in patients with cardio-
genic shock associated with LVOTO, inotropic agents,
vasodilators, and diuretic agents, as well as intra-
aortic balloon counterpulsation may lead to wors-
ening of shock and worse outcomes (4–6). Balloon
deﬂation further accelerates the blood ﬂow across the
LVOT, thereby increasing systolic negative pressure
in the aorta and LVOT pressure gradients (5,6).Emre Yalcinkaya, MD*
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J Interv Cardiol 2009;22:444–52.REPLY: Complexity of Assessment and
Management of Tako-Tsubo CardiomyopathyWe are grateful to Drs. Yalcinkaya and Celik for their
interest in the results of our study (1). The diagnosis
of Tako-Tsubo cardiomyopathy (TTC) is sometimes
challenging, and a detailed knowledge of this peculiar
syndrome is required. Recently, our group proposed a
revised form of the current diagnostic criteria for
TTC that might increase the likelihood of correctly
identifying this entity (2). We acknowledge that an
integrated multi-imaging approach seems reasonable
in TTC, especially when multiple etiologies atpresentation deserve an accurate diagnostic workup.
Cardiac magnetic resonance (CMR) imaging provides
useful information in differential diagnosis to
conﬁrm or rule out TTC. In a large, prospective,
multicenter study, TTC was correctly identiﬁed by
CMR performed at a median of 3 days after hospital
admission, but no information was reported as to
whether unstable patients were enrolled (1 patient
with cardiogenic shock did not undergo CMR) (3). In
our opinion, CMR should be considered as an alter-
native technique to echocardiography, and should
not be performed in all patients, but only in some
difﬁcult and challenging cases (4). In addition,
because of its limited availability, the necessity of
leaving the intensive care unit, and the duration of
the examination, the diagnostic performance of CMR
in unstable patients makes the risk-to-beneﬁt ratio
unfavorable. As for treatment of TTC, very few data
are available in this ﬁeld. Obviously, caution is
required for the treatment of patients with left
ventricular outﬂow tract obstruction. In this patient
subset, beta-blockers and ﬂuids are the ﬁrst-line
treatment options. In our experience, intra-aortic
balloon pump should only be used in patients with
persistent cardiac shock who do not respond to ﬂuid
administration. Generally, inotropic agents should
be avoided in these patients, but if the treatment
is deemed necessary, we think that norepinephrine
rather than epinephrine should be preferred. Veno-
arterial extracorporeal membrane oxygenation has
been reported as rescue therapy in severe cardiogenic
shock refractory to medical treatment and intra-aortic
balloon pump in some TTC patients (5). Therefore,
therapy should be tailored to different patients’
characteristics. Echocardiography is more suitable for
bedside monitoring of the dynamic and unique evo-
lution of TTC and should be considered the preferred
imaging modality even for therapy guidance.Rodolfo Citro, MD, PhD*
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